Tags Archive Navigation
-
介质释放,介质释放 地下Venture announce positive efficicacy and safety data for annovel treatment for babies<5kg with malaria -
存储,存储 A partnership against epilepsy -
介质释放,介质释放 Novartis and Medicines for Malaria Venture announce decision to move to Phase3study fornovel ganaplacide/lumefantrine-SDF combination in adults and children with malaria -
Featured News 世界第一天2022:Raising awareness on the importance of eye health -
介质释放,介质释放 Novartis renews commitment to neglected tropical disease and malaria elimination,investing USD250 million over five years to research and develop new treatments -
存储,存储 单轴轴轴轴颈内衬板 -
介质释放,介质释放 Novartis announces partnership with the American Society of Hematology to fight sickle cell disease in Sub-Saharan Africa -
介质释放,介质释放 非水平ganaplacide/lumefantrine combination in children with malaria -
介质释放,介质释放 Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa -
介质释放,介质释放 Novartis and the Bill&Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease -
介质释放,介质释放 1个城市规划的Novartis reaches milestone delivery of 1 billion courses of antimalarial treatment -
介质释放,介质释放 Novartis global survey uncovers profound and often under-reported effects on siccle cell disease patients